-
ARTIFICIAL INTELLIGENCE-DRIVEN CLINICAL DRUG REPORT GENERATION
Feb 25, 2026, 14:42 PM -
THE ANALYTICAL FRAMEWORK OF CLINICAL TRIALS EVALUATING CLINICAL OUTCOMES OF ARTIFICIAL INTELLIGENCE-BASED DIGITAL HEALTH INTERVENTIONS FOR MENTAL HEALTH DISORDERS: A SYSTEMATIC LITERATURE REVIEW
Feb 25, 2026, 14:42 PM -
GLP-1 THERAPY IMPROVES GLYCEMIC CONTROL WITH NO DIFFERENCE IN MEDICAL SPENDING: A REAL-WORLD EFFECTIVENESS STUDY
Feb 25, 2026, 14:42 PM -
EARLY REAL-WORLD ADHERENCE TO MRI SAFETY SURVEILLANCE AFTER LECANEMAB INITIATION AMONG MEDICARE BENEFICIARIES
Feb 25, 2026, 14:42 PM -
UNDERSTANDING PRIORITIES IN HEALTH ECONOMICS: MAPPING COST-EFFECTIVENESS AND DISEASE BURDEN TRENDS
Feb 25, 2026, 14:42 PM -
HOSPITALIZATION COSTS ASSOCIATED WITH 30-DAY UNPLANNED READMISSIONS AND POTENTIALLY PREVENTABLE READMISSIONS IN US OLDER PATIENTS WITH ALZHEIMER’S DISEASE AND RELATED DEMENTIAS
Feb 25, 2026, 14:42 PM -
UNDERSTANDING THE HEALTH-RELATED QUALITY OF LIFE BURDEN IN TRIGEMINAL NEURALGIA: A SYSTEMATIC LITERATURE REVIEW
Feb 25, 2026, 14:42 PM -
ORPHAN CELL AND GENE THERAPY APPROVALS IN THE US AND EUROPE: A COMPARATIVE ANALYSIS
Feb 25, 2026, 14:42 PM -
IDENTIFYING MEANINGFUL PATIENT SAVINGS ON GENERICS: DIRECT-TO-CONSUMER PRICES VS COMMERCIAL INSURANCE
Feb 25, 2026, 14:42 PM -
REAL-WORLD INSIGHTS INTO OBESITY PATHWAYS, PRESCRIBING, PATIENT COMPLEXITY, AND CARE GAPS THROUGH PRIMARY CARE DATABASES
Feb 25, 2026, 14:42 PM -
THE ECONOMIC BENEFIT OF A PRE-FILLED SYRINGE AS A ROUTE OF ADMINISTRATION: A TARGETED LITERATURE REVIEW
Feb 25, 2026, 14:42 PM -
A COST OUTCOMES ANALYSIS OF APIXABAN VERSUS RIVAROXABAN FOR THE TREATMENT OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE UNITED STATES
Feb 25, 2026, 14:42 PM -
DISEASE BURDEN OF DIABETIC KIDNEY DISEASE IN CHINA: A SYSTEMATIC LITERATURE REVIEW
Feb 25, 2026, 14:42 PM -
REAL-WORLD TREATMENT PATTERNS AND EFFICACY OF FIRST-LINE THERAPIES IN PATIENTS WITH MET EXON 14 SKIPPING-MUTATED NON-SMALL CELL LUNG CANCER
Feb 25, 2026, 14:42 PM -
REAL-WORLD EVIDENCE IN CANADA: BASELINE ESTIMATES TO SUPPORT HEALTH TECHNOLOGY ASSESSMENT
Feb 25, 2026, 14:42 PM -
COMPARATIVE CARDIOVASCULAR RISK IN U.S. POSTMENOPAUSAL WOMEN STARTING ROMOSOZUMAB VS DENOSUMAB: A HIGH-DIMENSIONAL INVERSE PROBABILITY OF SELECTION WEIGHTING ANALYSIS FOR MISSING CARDIOVASCULAR RISK FACTORS
Feb 25, 2026, 14:42 PM -
CLINICIAN TESTING OF A PREFERENCE-BASED MEASURE TO TEST SENSITIVITY AND RELEVANCE FOR UTILITIES ESTIMATION IN EARLY HD
Feb 25, 2026, 14:42 PM -
EVALUATING INITIAL MEDICATION ADHERENCE THRESHOLDS AS PREDICTORS OF CONTINUATION ADHERENCE AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A CLAIMS-BASED ANALYSIS
Feb 25, 2026, 14:42 PM -
MEASURING FUNCTIONAL ABILITIES AND ASSISTANCE LEVEL IN NIEMANN-PICK DISEASE TYPE C AND GM2 GANGLIOSIDOSES
Feb 25, 2026, 14:42 PM -
A FRAMEWORK FOR INCORPORATING DISTANCE-TO-CARE METRICS IN CANCER OUTCOMES RESEARCH: EXPLORATORY INSIGHTS USING REAL-WORLD DATA FROM A NETWORK OF COMMUNITY PRACTICES
Feb 25, 2026, 14:42 PM
